Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma

Human Pathology

Volumn 44, Issue 10, 2013, Pages 2071-2074

  Brozyna, Anna A ^a   Jóźwicki, Wojciech ^a   Carlson, J Andrew ^b   Slominski, Andrzej T ^c  

^a Prof Franciszek ukaszczyk Memorial Hospital   (Poland)

^b ALBANY MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Melanin; Melanogenesis; Melanoma; Metastatic melanoma; Survival

Indexed keywords

MELANIN;

AMELANOTIC MELANOMA; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; LABELING INDEX; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MELANOGENESIS; MELANOMA CELL; MELANOSIS; METASTATIC MELANOMA; MITOSIS RATE; OVERALL SURVIVAL; TUMOR NECROSIS;

MELANIN; MELANOGENESIS; MELANOMA; METASTATIC MELANOMA; SURVIVAL;

COMORBIDITY; DISEASE-FREE SURVIVAL; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; MELANOSIS; NEOPLASM STAGING; POLAND; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 84884411959     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.02.022     Document Type: Article

References (13)

1. A. Slominski, D.J. Tobin, S. Shibahara, and J. Wortsman Melanin pigmentation in mammalian skin and its hormonal regulation Physiol Rev 84 2004 1155 1228
2. A. Slominski, M.A. Zmijewski, and J. Pawelek l-Tyrosine and l-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions Pigment Cell Melanoma Res 25 2012 14 27
3. F.L. Meyskens Jr., P.J. Farmer, S. Yang, and H. Anton-Culver New perspectives on melanoma pathogenesis and chemoprevention Recent Results Cancer Res 174 2007 191 195
4. R. Lazova, and J.M. Pawelek Why do melanomas get so dark? Exp Dermatol 18 2009 934 938
5. A. Slominski, B. Zbytek, and R. Slominski Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells Int J Cancer 124 2009 1470 1477
6. A.A. Brozyna, L. VanMiddlesworth, and A.T. Slominski Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy Int J Cancer 123 2008 1448 1456
7. A.A. Brozyna, W. Jozwicki, Z. Janjetovic, and A.T. Slominski Expression of vitamin D receptor decreases during progression of pigmented skin lesions Hum Pathol 42 2011 618 631
8. A. Slominski, R. Paus, and M.C. Mihm Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis Anticancer Res 18 1998 3709 3715
9. A. Hauschild, J.J. Grob, and L.V. Demidov Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial Lancet 380 2012 358 365
10. V.A. Nikolaou, A.J. Stratigos, K.T. Flaherty, and H. Tsao Melanoma: new insights and new therapies J Invest Dermatol 132 2012 854 863
11. E. Livingstone, L. Zimmer, J. Vaubel, and D. Schadendorf Current advances and perspectives in the treatment of advanced melanoma J Dtsch Dermatol Ges 10 2012 319 325
12. D. Mitra, X. Luo, and A. Morgan An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background Nature 491 2012 449 453
13. S. Gidanian, M. Mentelle, F.L. Meyskens Jr., and P.J. Farmer Melanosomal damage in normal human melanocytes induced by UVB and metal uptake - a basis for the pro-oxidant state of melanoma Photochem Photobiol 84 2008 556 564